OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Nanomaterials in tumor immunotherapy: new strategies and challenges
Xudong Zhu, Shenglong Li
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 80
Xudong Zhu, Shenglong Li
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 80
Showing 26-50 of 80 citing articles:
Multifunctional nano-in-micro delivery systems for targeted therapy in fundus neovascularization diseases
Xin Liu, Keke Huang, Fuxiao Zhang, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 3
Xin Liu, Keke Huang, Fuxiao Zhang, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 3
Current Trends and Innovative Approaches in Cancer Immunotherapy
Jae-Chang Kim, Ruby Maharjan, Jonghyuck Park
AAPS PharmSciTech (2024) Vol. 25, Iss. 6
Closed Access | Times Cited: 3
Jae-Chang Kim, Ruby Maharjan, Jonghyuck Park
AAPS PharmSciTech (2024) Vol. 25, Iss. 6
Closed Access | Times Cited: 3
Tumor Microenvironment-Derived Exosomes: A Double-Edged Sword for Advanced T Cell-Based Immunotherapy
Ye Lu, Jiarong Zheng, Pei Lin, et al.
ACS Nano (2024)
Closed Access | Times Cited: 3
Ye Lu, Jiarong Zheng, Pei Lin, et al.
ACS Nano (2024)
Closed Access | Times Cited: 3
Advancing gastric cancer treatment: nanotechnology innovations and future prospects
Tengfei Yang, Lin Guo
Cell Biology and Toxicology (2024) Vol. 40, Iss. 1
Open Access | Times Cited: 3
Tengfei Yang, Lin Guo
Cell Biology and Toxicology (2024) Vol. 40, Iss. 1
Open Access | Times Cited: 3
Koetjapic acid: unveiling its potential as a saviour in the realm of biological and medicinal properties, with a focus on anticancer mechanism of action
Muhammad Armaghan, Khushbukhat Khan, Muhammad Irfan, et al.
European journal of medical research (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 3
Muhammad Armaghan, Khushbukhat Khan, Muhammad Irfan, et al.
European journal of medical research (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 3
Zeolitic imidazole framework-derived rich-Zn-Co3O4/N-doped porous carbon with multiple enzyme-like activities for synergistic cancer therapy
Zhong Yulin, Xu Zhang, Ai‐Jun Wang, et al.
Journal of Colloid and Interface Science (2024) Vol. 665, pp. 1065-1078
Closed Access | Times Cited: 3
Zhong Yulin, Xu Zhang, Ai‐Jun Wang, et al.
Journal of Colloid and Interface Science (2024) Vol. 665, pp. 1065-1078
Closed Access | Times Cited: 3
Nanoparticle-Mediated Synergistic Chemoimmunotherapy for Cancer Treatment
Xiaoxue Lang, Xiangtao Wang, Meihua Han, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 4533-4568
Open Access | Times Cited: 3
Xiaoxue Lang, Xiangtao Wang, Meihua Han, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 4533-4568
Open Access | Times Cited: 3
Liposomal Nanomaterials: A Rising Star in Glioma Treatment
Yu Gan, Yingying Yu, Huizhe Xu, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 6757-6776
Open Access | Times Cited: 3
Yu Gan, Yingying Yu, Huizhe Xu, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 6757-6776
Open Access | Times Cited: 3
Advances in Nanoplatforms for Immunotherapy Applications Targeting the Tumor Microenvironment
Nannan Zhang, Junyu Zhou, Shun Li, et al.
Molecular Pharmaceutics (2024)
Closed Access | Times Cited: 2
Nannan Zhang, Junyu Zhou, Shun Li, et al.
Molecular Pharmaceutics (2024)
Closed Access | Times Cited: 2
In silico ADMET profiling of Docetaxel and development of camel milk derived liposomes nanocarriers for sustained release of Docetaxel in triple negative breast cancer
Kousain Kousar, S Shafiq, Syeda Tahira Sherazi, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
Kousain Kousar, S Shafiq, Syeda Tahira Sherazi, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
What role does GPR65 play in the progression of osteosarcoma? Its mechanism and clinical significance
Qi Jin, Sihang Liu, Zhirui Zhang
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 2
Qi Jin, Sihang Liu, Zhirui Zhang
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 2
Defect-rich sonosensitizers based on CeO2 with Schottky heterojunctions for boosting sonodynamic/chemodynamic synergistic therapy
Haiyang Zheng, Na Yin, Kehong Lv, et al.
Journal of Materials Chemistry B (2024) Vol. 12, Iss. 17, pp. 4162-4171
Closed Access | Times Cited: 2
Haiyang Zheng, Na Yin, Kehong Lv, et al.
Journal of Materials Chemistry B (2024) Vol. 12, Iss. 17, pp. 4162-4171
Closed Access | Times Cited: 2
Immunoreactive Microenvironment Modulator GBP5 Suppresses Ovarian Cancer Progression by Inducing Canonical Pyroptosis
Chang Zou, Jiacheng Shen, Fangfang Xu, et al.
Journal of Cancer (2024) Vol. 15, Iss. 11, pp. 3510-3530
Open Access | Times Cited: 2
Chang Zou, Jiacheng Shen, Fangfang Xu, et al.
Journal of Cancer (2024) Vol. 15, Iss. 11, pp. 3510-3530
Open Access | Times Cited: 2
Nanomaterial-Driven Precision Immunomodulation: A New Paradigm in Therapeutic Interventions
Alaa A. A. Aljabali, Mohammad A. Obeid, Omar Gammoh, et al.
Cancers (2024) Vol. 16, Iss. 11, pp. 2030-2030
Open Access | Times Cited: 2
Alaa A. A. Aljabali, Mohammad A. Obeid, Omar Gammoh, et al.
Cancers (2024) Vol. 16, Iss. 11, pp. 2030-2030
Open Access | Times Cited: 2
Regulation of IFP in solid tumors through acoustic pressure to enhance infiltration of nanoparticles of various sizes
Yangcheng He, Yuyi Feng, Danxai Qiu, et al.
Journal of drug targeting (2024) Vol. 32, Iss. 8, pp. 964-976
Closed Access | Times Cited: 2
Yangcheng He, Yuyi Feng, Danxai Qiu, et al.
Journal of drug targeting (2024) Vol. 32, Iss. 8, pp. 964-976
Closed Access | Times Cited: 2
Resveratrol suppresses liver cancer progression by downregulating AKR1C3: targeting HCC with HSA nanomaterial as a carrier to enhance therapeutic efficacy
Ying Wang, Longxiang Su, Zhansheng Hu, et al.
APOPTOSIS (2024) Vol. 29, Iss. 9-10, pp. 1429-1453
Closed Access | Times Cited: 2
Ying Wang, Longxiang Su, Zhansheng Hu, et al.
APOPTOSIS (2024) Vol. 29, Iss. 9-10, pp. 1429-1453
Closed Access | Times Cited: 2
Recent Advances in Nanomaterial‐Mediated Cell Death for Cancer Therapy
Min Luo, Yuanmin Wang, Fukun Zhao, et al.
Advanced Healthcare Materials (2024)
Closed Access | Times Cited: 2
Min Luo, Yuanmin Wang, Fukun Zhao, et al.
Advanced Healthcare Materials (2024)
Closed Access | Times Cited: 2
Research progress of calcium carbonate nanomaterials in cancer therapy: challenge and opportunity
Tiantian Liang, Zongqi Feng, Xiao Zhang, et al.
Frontiers in Bioengineering and Biotechnology (2023) Vol. 11
Open Access | Times Cited: 5
Tiantian Liang, Zongqi Feng, Xiao Zhang, et al.
Frontiers in Bioengineering and Biotechnology (2023) Vol. 11
Open Access | Times Cited: 5
Nanoengineering of Vaccine Nanoparticles via Templating of Metal–Organic Frameworks for Tumor Immunotherapy
Yujia Liu, Ning Wang, Mengqi Li, et al.
Chemistry of Materials (2024) Vol. 36, Iss. 10, pp. 5017-5027
Closed Access | Times Cited: 1
Yujia Liu, Ning Wang, Mengqi Li, et al.
Chemistry of Materials (2024) Vol. 36, Iss. 10, pp. 5017-5027
Closed Access | Times Cited: 1
Nanomaterial-Based Strategies for Attenuating T-Cell-Mediated Immunodepression in Stroke Patients: Advancing Research Perspectives
Yan Wang, Cuiying Liu, Yanhong Ren, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 5793-5812
Open Access | Times Cited: 1
Yan Wang, Cuiying Liu, Yanhong Ren, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 5793-5812
Open Access | Times Cited: 1
Targeted therapy for leukemia based on nanomaterials
S. B. Qian, Cuiping Zheng, Yanfang Wu, et al.
Heliyon (2024) Vol. 10, Iss. 15, pp. e34951-e34951
Open Access | Times Cited: 1
S. B. Qian, Cuiping Zheng, Yanfang Wu, et al.
Heliyon (2024) Vol. 10, Iss. 15, pp. e34951-e34951
Open Access | Times Cited: 1
Near-infrared-II photocharging nanozyme for enhanced tumor immunotherapy
Anshuo Li, Shuzhen Chu, Meng Yuan, et al.
Journal of Colloid and Interface Science (2024) Vol. 676, pp. 783-794
Closed Access | Times Cited: 1
Anshuo Li, Shuzhen Chu, Meng Yuan, et al.
Journal of Colloid and Interface Science (2024) Vol. 676, pp. 783-794
Closed Access | Times Cited: 1
Immune landscape of hepatocellular carcinoma: From dysregulation of the immune responses to the potential immunotherapies
Atieh Pourbagheri‐Sigaroodi, Majid Momeny, Reza Yazdani, et al.
Cell Biochemistry and Function (2024) Vol. 42, Iss. 5
Closed Access | Times Cited: 1
Atieh Pourbagheri‐Sigaroodi, Majid Momeny, Reza Yazdani, et al.
Cell Biochemistry and Function (2024) Vol. 42, Iss. 5
Closed Access | Times Cited: 1
A temperature-responsive dual-hormone foam nanoengine improves rectal absorptivity of insulin-pramlintide for diabetes treatment
Shujun Feng, Yu Zhang, Chunyuan Hou, et al.
Science Advances (2024) Vol. 10, Iss. 35
Open Access | Times Cited: 1
Shujun Feng, Yu Zhang, Chunyuan Hou, et al.
Science Advances (2024) Vol. 10, Iss. 35
Open Access | Times Cited: 1
Current status of nanoparticle-mediated immunogenic cell death in cancer immunotherapy
Tuan Hiep Tran, Thi Thu Phuong Tran
International Immunopharmacology (2024) Vol. 142, pp. 113085-113085
Closed Access | Times Cited: 1
Tuan Hiep Tran, Thi Thu Phuong Tran
International Immunopharmacology (2024) Vol. 142, pp. 113085-113085
Closed Access | Times Cited: 1